China Issues Ethical Guidelines for Human Gene Data Research

China’s Ministry of Science and Technology (MOST) has officially released the “Ethical Guidelines for Human Gene Data Research,” a landmark framework designed to regulate the ethical collection, storage, and use of genetic information in scientific research. Published on May 25, the guidelines address growing concerns about data privacy, genetic discrimination, and biosafety in an era of rapid advances in gene sequencing and big-data analytics.

Drafted by the Life Sciences Ethics Subcommittee of the National Science and Technology Ethics Committee, the guidelines define human gene data as information obtained from biological samples — including cells, tissues, organs, and bodily fluids — that directly reflects human genetic information, described as the basic “blueprint of life” determining growth, development, physiological functions, and disease susceptibility.

Five Core Ethical Principles

The guidelines establish five foundational ethical principles that all gene data research must follow: promoting well-being, respecting autonomy, controlling risks, do no harm and prevent abuse, and fairness and justice. According to Xinhua News, research activities must aim to promote human health, improve disease prevention, diagnosis, and treatment, and enhance social public interest.

For applications carrying major uncertainty, cross-border risks, or potential cross-generational impacts, the guidelines require a prudent approach with comprehensive risk assessment before implementation. Researchers must follow principles of scientific rationality, legitimate purpose, and minimum necessity.

Privacy Protection and Data Security

A central focus of the guidelines is genetic privacy protection. Researchers are explicitly prohibited from conducting data mining or using genetic data for privacy violations. Privacy protection measures must be adopted according to data sensitivity and risk levels throughout the research process.

In the event of a data breach — if gene data is leaked, tampered with, or lost — data processors must immediately activate emergency plans, report to competent authorities, and take remedial measures, as detailed in the authoritative interpretation published by Science and Technology Daily.

The guidelines explicitly prohibit genetic discrimination, particularly against minority groups and genetically isolated populations. Data collection scope and sharing boundaries must be strictly limited to prevent improper aggregation, identification, or labeling of group-specific genetic information.

In a significant procedural innovation, the guidelines introduce “broad consent” and “dynamic consent” mechanisms, allowing for evolving gene data usage and reasonable secondary use in research while maintaining participant autonomy. “Putting well-being first means all research activities must be people-centered,” said Cong Bin, an academician at the Chinese Academy of Engineering and member of the Life Sciences Ethics Subcommittee, as quoted by Xinhua.

Expert Assessment: A Key Step Forward

Experts have hailed the guidelines as a pivotal development in China’s bioethics governance. “The release of this document marks a key step in China’s ethical governance of human gene data research, formally moving from ‘principle-based advocacy’ to ‘refined guidance,’” Cong Bin told Science and Technology Daily.

Peng Yaojin, a researcher at the Institute of Zoology, Chinese Academy of Sciences, emphasized the sensitivity of human gene data, noting that it concerns not only individual privacy and personality rights but also family, group, and even national biosafety. He warned of risks including privacy leakage, genetic discrimination, data abuse, and security loss of control during collection, storage, use, sharing, and external provision.

Broader Context: China’s Evolving Ethics Framework

The new guidelines are the latest addition to China’s rapidly developing science and technology ethics governance system. In March 2022, China issued its first national-level science and technology ethics governance document, establishing a comprehensive framework for regulating emerging technologies. This was followed by ethical guidelines for brain-computer interface research in February 2024 and for human genome editing research in July 2024.

The guidelines also sit within a broader legal framework including the Biosecurity Law, Personal Information Protection Law, and Data Security Law — all enacted in 2021 — as well as regulations on human genetic resources management.

What’s Next

As the guidelines move from text to practice, the focus will shift to implementation. Experts emphasize that research institutions must integrate the requirements into project life-cycle management, strengthen internal ethics review mechanisms, and build robust data security systems. Researchers, meanwhile, must strengthen their awareness of ethical boundaries and regulatory compliance.

“The implementation of the guidelines will effectively guide China’s human gene data research to progress steadily on a standardized track, ultimately achieving a dynamic balance between releasing technological innovation potential and assuming ethical responsibility,” Cong Bin concluded.

The guidelines raise important questions about enforcement mechanisms, interaction with existing laws, and implications for international research collaborations — issues that will likely shape the next phase of China’s bioethics governance.